<?xml version='1.0' encoding='utf-8'?>
<document id="24929949"><sentence text="Effect of fosamprenavir/ritonavir on the pharmacokinetics of single-dose olanzapine in healthy volunteers."><entity charOffset="10-23" id="DDI-PubMed.24929949.s1.e0" text="fosamprenavir" /><entity charOffset="24-33" id="DDI-PubMed.24929949.s1.e1" text="ritonavir" /><entity charOffset="73-83" id="DDI-PubMed.24929949.s1.e2" text="olanzapine" /><pair ddi="false" e1="DDI-PubMed.24929949.s1.e0" e2="DDI-PubMed.24929949.s1.e0" /><pair ddi="false" e1="DDI-PubMed.24929949.s1.e0" e2="DDI-PubMed.24929949.s1.e1" /><pair ddi="false" e1="DDI-PubMed.24929949.s1.e0" e2="DDI-PubMed.24929949.s1.e2" /><pair ddi="false" e1="DDI-PubMed.24929949.s1.e1" e2="DDI-PubMed.24929949.s1.e1" /><pair ddi="false" e1="DDI-PubMed.24929949.s1.e1" e2="DDI-PubMed.24929949.s1.e2" /></sentence><sentence text="Psychosis and other mental illnesses are common in HIV-infected patients" /><sentence text=" Olanzapine is one of the preferred antipsychotic agents for the treatment of schizophrenia"><entity charOffset="1-11" id="DDI-PubMed.24929949.s3.e0" text="Olanzapine" /></sentence><sentence text=" Olanzapine is primarily metabolised by CYP1A2 and uridine diphosphate glucuronosyltransferase (UGT)"><entity charOffset="1-11" id="DDI-PubMed.24929949.s4.e0" text="Olanzapine" /><entity charOffset="51-70" id="DDI-PubMed.24929949.s4.e1" text="uridine diphosphate" /><pair ddi="false" e1="DDI-PubMed.24929949.s4.e0" e2="DDI-PubMed.24929949.s4.e0" /><pair ddi="false" e1="DDI-PubMed.24929949.s4.e0" e2="DDI-PubMed.24929949.s4.e1" /></sentence><sentence text=" High-dose ritonavir has been shown to increase olanzapine elimination through induction of CYP1A2 and/or UGT, but the effect of low-dose ritonavir on olanzapine pharmacokinetics is unknown"><entity charOffset="11-20" id="DDI-PubMed.24929949.s5.e0" text="ritonavir" /><entity charOffset="48-58" id="DDI-PubMed.24929949.s5.e1" text="olanzapine" /><entity charOffset="138-147" id="DDI-PubMed.24929949.s5.e2" text="ritonavir" /><entity charOffset="151-161" id="DDI-PubMed.24929949.s5.e3" text="olanzapine" /><pair ddi="false" e1="DDI-PubMed.24929949.s5.e0" e2="DDI-PubMed.24929949.s5.e0" /><pair ddi="false" e1="DDI-PubMed.24929949.s5.e0" e2="DDI-PubMed.24929949.s5.e1" /><pair ddi="false" e1="DDI-PubMed.24929949.s5.e0" e2="DDI-PubMed.24929949.s5.e2" /><pair ddi="false" e1="DDI-PubMed.24929949.s5.e0" e2="DDI-PubMed.24929949.s5.e3" /><pair ddi="false" e1="DDI-PubMed.24929949.s5.e1" e2="DDI-PubMed.24929949.s5.e1" /><pair ddi="false" e1="DDI-PubMed.24929949.s5.e1" e2="DDI-PubMed.24929949.s5.e2" /><pair ddi="false" e1="DDI-PubMed.24929949.s5.e1" e2="DDI-PubMed.24929949.s5.e3" /><pair ddi="false" e1="DDI-PubMed.24929949.s5.e2" e2="DDI-PubMed.24929949.s5.e2" /><pair ddi="false" e1="DDI-PubMed.24929949.s5.e2" e2="DDI-PubMed.24929949.s5.e3" /></sentence><sentence text=" Fosamprenavir is an HIV protease inhibitor that is boosted by low-dose ritonavir"><entity charOffset="1-14" id="DDI-PubMed.24929949.s6.e0" text="Fosamprenavir" /><entity charOffset="72-81" id="DDI-PubMed.24929949.s6.e1" text="ritonavir" /><pair ddi="false" e1="DDI-PubMed.24929949.s6.e0" e2="DDI-PubMed.24929949.s6.e0" /><pair ddi="false" e1="DDI-PubMed.24929949.s6.e0" e2="DDI-PubMed.24929949.s6.e1" /></sentence><sentence text=" To compensate for the induction of olanzapine metabolism by fosamprenavir/ritonavir, we hypothesised that a dose increase of olanzapine to 15 mg with fosamprenavir/ritonavir would lead to a similar area under the concentration-time curve (AUC) compared with olanzapine 10 mg alone"><entity charOffset="36-46" id="DDI-PubMed.24929949.s7.e0" text="olanzapine" /><entity charOffset="61-74" id="DDI-PubMed.24929949.s7.e1" text="fosamprenavir" /><entity charOffset="75-84" id="DDI-PubMed.24929949.s7.e2" text="ritonavir" /><entity charOffset="126-136" id="DDI-PubMed.24929949.s7.e3" text="olanzapine" /><entity charOffset="151-164" id="DDI-PubMed.24929949.s7.e4" text="fosamprenavir" /><entity charOffset="165-174" id="DDI-PubMed.24929949.s7.e5" text="ritonavir" /><entity charOffset="259-269" id="DDI-PubMed.24929949.s7.e6" text="olanzapine" /><pair ddi="false" e1="DDI-PubMed.24929949.s7.e0" e2="DDI-PubMed.24929949.s7.e0" /><pair ddi="false" e1="DDI-PubMed.24929949.s7.e0" e2="DDI-PubMed.24929949.s7.e1" /><pair ddi="false" e1="DDI-PubMed.24929949.s7.e0" e2="DDI-PubMed.24929949.s7.e2" /><pair ddi="false" e1="DDI-PubMed.24929949.s7.e0" e2="DDI-PubMed.24929949.s7.e3" /><pair ddi="false" e1="DDI-PubMed.24929949.s7.e0" e2="DDI-PubMed.24929949.s7.e4" /><pair ddi="false" e1="DDI-PubMed.24929949.s7.e0" e2="DDI-PubMed.24929949.s7.e5" /><pair ddi="false" e1="DDI-PubMed.24929949.s7.e0" e2="DDI-PubMed.24929949.s7.e6" /><pair ddi="false" e1="DDI-PubMed.24929949.s7.e1" e2="DDI-PubMed.24929949.s7.e1" /><pair ddi="false" e1="DDI-PubMed.24929949.s7.e1" e2="DDI-PubMed.24929949.s7.e2" /><pair ddi="false" e1="DDI-PubMed.24929949.s7.e1" e2="DDI-PubMed.24929949.s7.e3" /><pair ddi="false" e1="DDI-PubMed.24929949.s7.e1" e2="DDI-PubMed.24929949.s7.e4" /><pair ddi="false" e1="DDI-PubMed.24929949.s7.e1" e2="DDI-PubMed.24929949.s7.e5" /><pair ddi="false" e1="DDI-PubMed.24929949.s7.e1" e2="DDI-PubMed.24929949.s7.e6" /><pair ddi="false" e1="DDI-PubMed.24929949.s7.e2" e2="DDI-PubMed.24929949.s7.e2" /><pair ddi="false" e1="DDI-PubMed.24929949.s7.e2" e2="DDI-PubMed.24929949.s7.e3" /><pair ddi="false" e1="DDI-PubMed.24929949.s7.e2" e2="DDI-PubMed.24929949.s7.e4" /><pair ddi="false" e1="DDI-PubMed.24929949.s7.e2" e2="DDI-PubMed.24929949.s7.e5" /><pair ddi="false" e1="DDI-PubMed.24929949.s7.e2" e2="DDI-PubMed.24929949.s7.e6" /><pair ddi="false" e1="DDI-PubMed.24929949.s7.e3" e2="DDI-PubMed.24929949.s7.e3" /><pair ddi="false" e1="DDI-PubMed.24929949.s7.e3" e2="DDI-PubMed.24929949.s7.e4" /><pair ddi="false" e1="DDI-PubMed.24929949.s7.e3" e2="DDI-PubMed.24929949.s7.e5" /><pair ddi="false" e1="DDI-PubMed.24929949.s7.e3" e2="DDI-PubMed.24929949.s7.e6" /><pair ddi="false" e1="DDI-PubMed.24929949.s7.e4" e2="DDI-PubMed.24929949.s7.e4" /><pair ddi="false" e1="DDI-PubMed.24929949.s7.e4" e2="DDI-PubMed.24929949.s7.e5" /><pair ddi="false" e1="DDI-PubMed.24929949.s7.e4" e2="DDI-PubMed.24929949.s7.e6" /><pair ddi="false" e1="DDI-PubMed.24929949.s7.e5" e2="DDI-PubMed.24929949.s7.e5" /><pair ddi="false" e1="DDI-PubMed.24929949.s7.e5" e2="DDI-PubMed.24929949.s7.e6" /></sentence><sentence text=" An open-label, randomised, two-period, cross-over, single-centre trial was conducted in 24 healthy volunteers" /><sentence text=" Subjects were randomised to one of the following treatments: (A) fosamprenavir/ritonavir 700/100 mg twice daily (b"><entity charOffset="66-79" id="DDI-PubMed.24929949.s9.e0" text="fosamprenavir" /><entity charOffset="80-89" id="DDI-PubMed.24929949.s9.e1" text="ritonavir" /><pair ddi="false" e1="DDI-PubMed.24929949.s9.e0" e2="DDI-PubMed.24929949.s9.e0" /><pair ddi="false" e1="DDI-PubMed.24929949.s9.e0" e2="DDI-PubMed.24929949.s9.e1" /></sentence><sentence text="i" /><sentence text="d" /><sentence text=") for 16 days with a single dose of olanzapine 15 mg on Day 13, a wash-out period of 31 days and a single dose of olanzapine 10 mg on Day 48; or (B) the same medication in reverse order"><entity charOffset="36-46" id="DDI-PubMed.24929949.s12.e0" text="olanzapine" /><entity charOffset="114-124" id="DDI-PubMed.24929949.s12.e1" text="olanzapine" /><pair ddi="false" e1="DDI-PubMed.24929949.s12.e0" e2="DDI-PubMed.24929949.s12.e0" /><pair ddi="false" e1="DDI-PubMed.24929949.s12.e0" e2="DDI-PubMed.24929949.s12.e1" /></sentence><sentence text=" Twenty subjects completed the trial" /><sentence text=" The geometric mean ratios (90% CI) of olanzapine AUClast, maximum drug concentration (C(max)) and apparent elimination half-life (t(1/2)) when taken with fosamprenavir/ritonavir versus olanzapine alone were 1"><entity charOffset="39-49" id="DDI-PubMed.24929949.s14.e0" text="olanzapine" /><entity charOffset="155-168" id="DDI-PubMed.24929949.s14.e1" text="fosamprenavir" /><entity charOffset="169-178" id="DDI-PubMed.24929949.s14.e2" text="ritonavir" /><entity charOffset="186-196" id="DDI-PubMed.24929949.s14.e3" text="olanzapine" /><pair ddi="false" e1="DDI-PubMed.24929949.s14.e0" e2="DDI-PubMed.24929949.s14.e0" /><pair ddi="false" e1="DDI-PubMed.24929949.s14.e0" e2="DDI-PubMed.24929949.s14.e1" /><pair ddi="false" e1="DDI-PubMed.24929949.s14.e0" e2="DDI-PubMed.24929949.s14.e2" /><pair ddi="false" e1="DDI-PubMed.24929949.s14.e0" e2="DDI-PubMed.24929949.s14.e3" /><pair ddi="false" e1="DDI-PubMed.24929949.s14.e1" e2="DDI-PubMed.24929949.s14.e1" /><pair ddi="false" e1="DDI-PubMed.24929949.s14.e1" e2="DDI-PubMed.24929949.s14.e2" /><pair ddi="false" e1="DDI-PubMed.24929949.s14.e1" e2="DDI-PubMed.24929949.s14.e3" /><pair ddi="false" e1="DDI-PubMed.24929949.s14.e2" e2="DDI-PubMed.24929949.s14.e2" /><pair ddi="false" e1="DDI-PubMed.24929949.s14.e2" e2="DDI-PubMed.24929949.s14.e3" /></sentence><sentence text="00 (0" /><sentence text="93-1" /><sentence text="08), 1" /><sentence text="32 (1" /><sentence text="18-1" /><sentence text="47) and 0" /><sentence text="68 (0" /><sentence text="63-0" /><sentence text="74), respectively" /><sentence text=" Fosamprenavir/ritonavir 700/100 mg b"><entity charOffset="1-14" id="DDI-PubMed.24929949.s24.e0" text="Fosamprenavir" /><entity charOffset="15-24" id="DDI-PubMed.24929949.s24.e1" text="ritonavir" /><pair ddi="false" e1="DDI-PubMed.24929949.s24.e0" e2="DDI-PubMed.24929949.s24.e0" /><pair ddi="false" e1="DDI-PubMed.24929949.s24.e0" e2="DDI-PubMed.24929949.s24.e1" /></sentence><sentence text="i" /><sentence text="d" /><sentence text=" appeared to induce olanzapine metabolism"><entity charOffset="20-30" id="DDI-PubMed.24929949.s27.e0" text="olanzapine" /></sentence><sentence text=" We therefore propose a 50% dosage increase of olanzapine when combining with a ritonavir-boosted protease inhibitor"><entity charOffset="47-57" id="DDI-PubMed.24929949.s28.e0" text="olanzapine" /><entity charOffset="80-89" id="DDI-PubMed.24929949.s28.e1" text="ritonavir" /><pair ddi="false" e1="DDI-PubMed.24929949.s28.e0" e2="DDI-PubMed.24929949.s28.e0" /><pair ddi="false" e1="DDI-PubMed.24929949.s28.e0" e2="DDI-PubMed.24929949.s28.e1" /></sentence><sentence text="" /></document>